PubMed · 1985 · 19 citations · 12 references
Life SciencesImmunologyPharmacologyAutoimmunityImmunopathologyImmunopharmacologyAutoantibodiesAutoimmune DiseasesAutoimmune Kidney DiseaseImmune-mediated Renal DiseaseRenal DiseaseSystemic Lupus ErythematosusCurative InterventionCurative TherapyGlomerular AutoimmunityLupus Nephritis TherapyProteinuria ReductionSystemic Lupus Erythematosus Models
FUT-175 (6-amidino-2-naphthyl p-guanidinobenzoate dimethanesulphonate), a new synthetic protease inhibitor, was administrated to (NZB x NZB) F1 mice in order to examine its influence on the development of autoimmune diseases. A dose (400 mg/kg of body weight) of FUT-175 has both prophylactic and curative effects on the development of lupus nephritis: mice showed a significantly low percentage of proteinuria, a marked decrease in BUN levels, and the lowest degree of glomerular damages. Dexamethasone had almost the same effect as FUT-175 (400 mg/kg), but it was slightly less effective than FUT-175. These results suggest that the administration of FUT-175 may become a viable strategy for the treatment of human autoimmune diseases.
12